| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,523 |
13,902 |
$3.63M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,082 |
9,575 |
$1.51M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,434 |
6,183 |
$1.45M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,767 |
8,449 |
$1.24M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,890 |
4,711 |
$1.03M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,301 |
3,236 |
$908K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,938 |
1,897 |
$781K |
| 80053 |
Comprehensive metabolic panel |
13,592 |
13,051 |
$748K |
| 36415 |
Collection of venous blood by venipuncture |
13,177 |
12,130 |
$699K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,943 |
2,889 |
$500K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,320 |
1,568 |
$431K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,421 |
1,347 |
$407K |
| 70450 |
Computed tomography, head or brain; without contrast material |
997 |
973 |
$350K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
800 |
788 |
$315K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,947 |
1,942 |
$288K |
| 81025 |
|
4,080 |
3,949 |
$258K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,805 |
1,800 |
$239K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,530 |
5,222 |
$239K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,270 |
1,270 |
$207K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,133 |
1,133 |
$206K |
| 99215 |
Prolong outpt/office vis |
1,136 |
1,129 |
$169K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,175 |
1,797 |
$159K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,903 |
4,657 |
$159K |
| 80061 |
Lipid panel |
6,484 |
6,469 |
$153K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,084 |
1,008 |
$141K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,280 |
3,275 |
$108K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,315 |
15,360 |
$103K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
428 |
406 |
$102K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,109 |
538 |
$99K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,307 |
1,306 |
$97K |
| 90686 |
|
2,522 |
2,513 |
$88K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,583 |
6,538 |
$78K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
429 |
428 |
$78K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
375 |
371 |
$71K |
| Q3014 |
Telehealth originating site facility fee |
1,226 |
1,170 |
$70K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
495 |
484 |
$70K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
998 |
994 |
$68K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,101 |
5,584 |
$57K |
| 71046 |
Radiologic examination, chest; 2 views |
2,028 |
1,996 |
$51K |
| 90715 |
|
1,303 |
1,296 |
$41K |
| 94010 |
|
214 |
212 |
$38K |
| 71045 |
Radiologic examination, chest; single view |
2,120 |
2,057 |
$37K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,289 |
2,086 |
$36K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,190 |
4,179 |
$35K |
| 86850 |
|
803 |
791 |
$35K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
499 |
495 |
$34K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
226 |
226 |
$33K |
| 97162 |
|
234 |
233 |
$32K |
| 84484 |
|
3,025 |
2,684 |
$32K |
| 99406 |
|
741 |
732 |
$29K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
24 |
24 |
$29K |
| 76830 |
Ultrasound, transvaginal |
443 |
440 |
$29K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
383 |
253 |
$29K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,853 |
2,871 |
$28K |
| 90375 |
|
12 |
12 |
$28K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,539 |
3,371 |
$24K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
102 |
100 |
$24K |
| 83690 |
|
4,660 |
4,431 |
$24K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
321 |
169 |
$23K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
998 |
994 |
$20K |
| 84439 |
|
1,888 |
1,867 |
$20K |
| 82607 |
|
1,632 |
1,628 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
535 |
523 |
$19K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,166 |
1,165 |
$19K |
| 73564 |
|
570 |
557 |
$19K |
| 83735 |
|
4,161 |
3,972 |
$17K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
344 |
335 |
$17K |
| 81001 |
|
4,655 |
4,483 |
$16K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
425 |
235 |
$15K |
| 71271 |
|
130 |
130 |
$15K |
| 73610 |
|
721 |
707 |
$14K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
343 |
342 |
$14K |
| 87634 |
|
578 |
574 |
$14K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
142 |
129 |
$14K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
36 |
36 |
$14K |
| 85027 |
|
2,047 |
2,013 |
$13K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
43 |
42 |
$13K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,515 |
2,383 |
$13K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
24 |
24 |
$12K |
| 80051 |
|
567 |
556 |
$12K |
| 73630 |
|
723 |
697 |
$12K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
155 |
154 |
$12K |
| 90651 |
|
229 |
229 |
$10K |
| 86901 |
|
849 |
836 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,858 |
1,807 |
$9K |
| 84450 |
|
1,767 |
1,724 |
$9K |
| 86900 |
|
849 |
836 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
975 |
739 |
$9K |
| 84702 |
|
1,175 |
1,070 |
$9K |
| 82728 |
|
601 |
595 |
$9K |
| 73030 |
|
370 |
366 |
$8K |
| 71250 |
|
44 |
44 |
$8K |
| 85610 |
|
1,373 |
1,135 |
$8K |
| 76642 |
|
183 |
183 |
$8K |
| 83880 |
|
253 |
237 |
$8K |
| 81003 |
|
4,063 |
3,979 |
$7K |
| 82565 |
|
1,022 |
994 |
$7K |
| 73130 |
|
349 |
341 |
$7K |
| 90675 |
|
43 |
14 |
$7K |
| 84466 |
|
844 |
837 |
$7K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
202 |
201 |
$7K |
| 87081 |
|
1,392 |
1,386 |
$7K |
| 82570 |
|
907 |
904 |
$6K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
43 |
42 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
221 |
215 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,185 |
4,052 |
$6K |
| 76801 |
|
79 |
79 |
$6K |
| 86803 |
|
473 |
473 |
$6K |
| 83540 |
|
1,039 |
1,031 |
$6K |
| 82043 |
|
801 |
800 |
$6K |
| 82247 |
|
1,502 |
1,469 |
$5K |
| 83605 |
|
1,417 |
1,228 |
$5K |
| 86618 |
|
658 |
652 |
$5K |
| 80076 |
|
227 |
225 |
$5K |
| 86140 |
|
917 |
877 |
$5K |
| 73110 |
|
302 |
289 |
$5K |
| 90734 |
|
211 |
211 |
$5K |
| 87077 |
|
693 |
657 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
32 |
29 |
$4K |
| 82040 |
|
1,418 |
1,393 |
$4K |
| 84153 |
|
386 |
386 |
$4K |
| 84520 |
|
579 |
567 |
$4K |
| 86580 |
|
162 |
152 |
$4K |
| 90656 |
|
202 |
202 |
$3K |
| 85652 |
|
959 |
923 |
$3K |
| 84155 |
|
1,130 |
1,114 |
$3K |
| 90670 |
|
107 |
106 |
$3K |
| 84480 |
|
303 |
301 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,398 |
1,389 |
$3K |
| 97161 |
|
25 |
25 |
$3K |
| 76770 |
|
14 |
14 |
$3K |
| 90732 |
|
57 |
57 |
$3K |
| 0064A |
|
85 |
84 |
$3K |
| 93971 |
|
26 |
26 |
$3K |
| 90677 |
|
35 |
35 |
$3K |
| 0001A |
|
70 |
69 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
531 |
441 |
$2K |
| 0002A |
|
69 |
68 |
$2K |
| 94060 |
|
13 |
13 |
$2K |
| 87186 |
|
535 |
508 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,168 |
3,895 |
$2K |
| 72110 |
|
63 |
63 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
77 |
75 |
$2K |
| 82746 |
|
150 |
150 |
$2K |
| 85379 |
|
258 |
256 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
175 |
174 |
$2K |
| 82948 |
|
1,368 |
1,107 |
$2K |
| 87070 |
|
357 |
353 |
$2K |
| 0004A |
|
43 |
43 |
$2K |
| 83655 |
|
129 |
129 |
$1K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
84 |
82 |
$1K |
| 87468 |
|
52 |
51 |
$1K |
| 99442 |
|
13 |
13 |
$1K |
| 82947 |
|
273 |
271 |
$1K |
| 76536 |
|
15 |
15 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
76 |
74 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,068 |
1,043 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
956 |
949 |
$1K |
| 91322 |
|
29 |
29 |
$1K |
| 90619 |
|
40 |
40 |
$1K |
| 82550 |
|
161 |
149 |
$915.16 |
| 87469 |
|
52 |
51 |
$883.80 |
| 87484 |
|
52 |
51 |
$883.80 |
| 87478 |
|
52 |
51 |
$883.80 |
| 87040 |
|
125 |
65 |
$861.96 |
| 80306 |
|
142 |
141 |
$856.77 |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$776.29 |
| 84460 |
|
69 |
66 |
$774.99 |
| 96376 |
|
152 |
136 |
$765.47 |
| 86666 |
|
171 |
94 |
$675.82 |
| 85730 |
|
151 |
148 |
$672.08 |
| 82150 |
|
113 |
112 |
$644.36 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
324 |
323 |
$621.42 |
| 94729 |
|
17 |
17 |
$550.39 |
| 0124A |
|
15 |
15 |
$540.45 |
| 97014 |
|
25 |
12 |
$512.38 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,841 |
2,733 |
$501.12 |
| 90700 |
|
27 |
27 |
$481.95 |
| 87476 |
|
26 |
26 |
$434.26 |
| 83550 |
|
146 |
146 |
$410.98 |
| 90480 |
|
28 |
28 |
$302.07 |
| 87481 |
|
12 |
12 |
$290.07 |
| 90633 |
|
14 |
14 |
$249.90 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
12 |
12 |
$232.08 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,289 |
2,175 |
$229.96 |
| 90710 |
|
12 |
12 |
$214.20 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
978 |
957 |
$196.72 |
| 87807 |
|
29 |
29 |
$191.75 |
| 86780 |
|
13 |
13 |
$171.95 |
| 86617 |
|
26 |
14 |
$159.88 |
| 83520 |
|
69 |
69 |
$154.14 |
| 73140 |
|
13 |
12 |
$141.96 |
| 73080 |
|
12 |
12 |
$115.56 |
| 86753 |
|
38 |
38 |
$100.16 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
207 |
183 |
$96.17 |
| 82803 |
|
13 |
13 |
$71.52 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
69 |
65 |
$67.11 |
| 86038 |
|
12 |
12 |
$50.46 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
234 |
203 |
$41.42 |
| 86308 |
|
12 |
12 |
$29.71 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
642 |
630 |
$29.38 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
37 |
37 |
$11.25 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
122 |
115 |
$10.44 |
| 80326 |
|
14 |
14 |
$10.00 |
| 80364 |
|
14 |
14 |
$10.00 |
| 80347 |
|
14 |
14 |
$10.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
72 |
69 |
$7.03 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13 |
13 |
$2.66 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
14 |
14 |
$0.39 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
23 |
22 |
$0.01 |
| 81513 |
|
12 |
12 |
$0.00 |
| 96127 |
|
56 |
56 |
$0.00 |